Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 17k
3 October 2019
P-003098-19
Question for written answer P-003098-19
to the Commission
Rule 138
Tudor Ciuhodaru (S&D)

 Subject:  Cardiovascular diseases

In the European Union, 49 million people live with cardiovascular disease (CVD). Every year, more than 1.8 million people die from CVD, mainly from heart disease and strokes, making it by far the leading cause of death, as proven by the latest Eurostat data. Apart from the human cost, CVD is a significant financial burden, costing the EU economy an estimated EUR 210 billion each year.

How does the Commission intend to reduce the burden of the leading cause of death in the EU and improve quality of life for the 49 million people living with CVD?

Last updated: 8 October 2019Legal notice